{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:18:32Z","timestamp":1758817112848,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.humpath.2016.12.030","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:30:13Z","timestamp":1487723413000},"page":"175-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["TCL-1\u2013positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy"],"prefix":"10.1016","volume":"65","author":[{"given":"Zhihong","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7333-7478","authenticated-orcid":false,"given":"Tsieh","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2016.12.030_bb0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(73)93135-8","article-title":"Prolymphocytic leukaemia of B and T cell type","volume":"2","author":"Catovsky","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2016.12.030_bb0010","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"270","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2016.12.030_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/KWJYBCCGTB90B6AE","article-title":"Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia\/lymphoma, and Sezary syndrome","volume":"127","author":"Foucar","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2016.12.030_bb0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2004-01-0002","article-title":"A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories","volume":"104","author":"Herling","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2016.12.030_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2007-07-101519","article-title":"High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia","volume":"111","author":"Herling","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2016.12.030_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/PAS.0000000000000272","article-title":"T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2016.12.030_bb0035","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2016.12.030_bb0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12185-012-1077-y","article-title":"T-cell prolymphocytic leukemia in Japan: is it a variant?","volume":"95","author":"Kameoka","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2016.12.030_bb0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.1998.00977.x","article-title":"Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d'Hematologie Cellulaire","volume":"103","author":"Garand","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2016.12.030_bb0050","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1038\/sj.onc.1204596","article-title":"The role of TCL1 in human T-cell leukemia","volume":"20","author":"Pekarsky","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2016.12.030_bb0055","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1073\/pnas.91.26.12530","article-title":"Identification of the TCL1 gene involved in T-cell malignancies","volume":"91","author":"Virgilio","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2016.12.030_bb0060","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1001\/jama.286.18.2308","article-title":"Molecular basis of mature T-cell leukemia","volume":"286","author":"Pekarsky","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2016.12.030_bb0065","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nrc1672","article-title":"The TCL1 family of oncoproteins: co-activators of transformation","volume":"5","author":"Teitell","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2016.12.030_bb0070","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2016.12.030_bb0075","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V98.8.2498","article-title":"Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry","volume":"98","author":"McKenna","year":"2001","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717300448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717300448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T20:41:01Z","timestamp":1601671261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717300448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":15,"alternative-id":["S0046817717300448"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2016.12.030","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TCL-1\u2013positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2016.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}